JP2009526526A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009526526A5 JP2009526526A5 JP2008554442A JP2008554442A JP2009526526A5 JP 2009526526 A5 JP2009526526 A5 JP 2009526526A5 JP 2008554442 A JP2008554442 A JP 2008554442A JP 2008554442 A JP2008554442 A JP 2008554442A JP 2009526526 A5 JP2009526526 A5 JP 2009526526A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- domain
- integral membrane
- membrane protein
- vaccine composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 101710154606 Hemagglutinin Proteins 0.000 claims 66
- 101710093908 Outer capsid protein VP4 Proteins 0.000 claims 66
- 101710135467 Outer capsid protein sigma-1 Proteins 0.000 claims 66
- 101710176177 Protein A56 Proteins 0.000 claims 66
- 239000000185 hemagglutinin Substances 0.000 claims 66
- 108010006232 Neuraminidase Proteins 0.000 claims 62
- 102000005348 Neuraminidase Human genes 0.000 claims 62
- 102000018697 Membrane Proteins Human genes 0.000 claims 57
- 108010052285 Membrane Proteins Proteins 0.000 claims 57
- 235000004252 protein component Nutrition 0.000 claims 57
- 239000000203 mixture Substances 0.000 claims 50
- 229960005486 vaccine Drugs 0.000 claims 42
- 102000036639 antigens Human genes 0.000 claims 39
- 108091007433 antigens Proteins 0.000 claims 39
- 239000000427 antigen Substances 0.000 claims 34
- 108010076363 licheninase Proteins 0.000 claims 27
- 150000007523 nucleic acids Chemical class 0.000 claims 26
- 102000004169 proteins and genes Human genes 0.000 claims 23
- 108090000623 proteins and genes Proteins 0.000 claims 23
- 241000196324 Embryophyta Species 0.000 claims 21
- 238000000034 method Methods 0.000 claims 21
- 108020004707 nucleic acids Proteins 0.000 claims 21
- 102000039446 nucleic acids Human genes 0.000 claims 21
- 235000018102 proteins Nutrition 0.000 claims 18
- 210000004027 cell Anatomy 0.000 claims 15
- 108020001507 fusion proteins Proteins 0.000 claims 15
- 102000037865 fusion proteins Human genes 0.000 claims 15
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 11
- 210000004899 c-terminal region Anatomy 0.000 claims 10
- 230000028993 immune response Effects 0.000 claims 10
- 208000037797 influenza A Diseases 0.000 claims 10
- 239000012528 membrane Substances 0.000 claims 10
- 241000219198 Brassica Species 0.000 claims 5
- 108091026890 Coding region Proteins 0.000 claims 5
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 5
- 238000003780 insertion Methods 0.000 claims 5
- 230000037431 insertion Effects 0.000 claims 5
- 235000003351 Brassica cretica Nutrition 0.000 claims 4
- 235000003343 Brassica rupestris Nutrition 0.000 claims 4
- QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 claims 4
- 239000003937 drug carrier Substances 0.000 claims 4
- 235000010460 mustard Nutrition 0.000 claims 4
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 claims 3
- 240000007377 Petunia x hybrida Species 0.000 claims 3
- 229960002715 nicotine Drugs 0.000 claims 3
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 claims 3
- 240000007124 Brassica oleracea Species 0.000 claims 2
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 claims 2
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 claims 2
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 claims 2
- 235000017647 Brassica oleracea var italica Nutrition 0.000 claims 2
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 claims 2
- 240000003259 Brassica oleracea var. botrytis Species 0.000 claims 2
- 235000010469 Glycine max Nutrition 0.000 claims 2
- 244000020551 Helianthus annuus Species 0.000 claims 2
- 235000003222 Helianthus annuus Nutrition 0.000 claims 2
- 235000014647 Lens culinaris subsp culinaris Nutrition 0.000 claims 2
- 244000043158 Lens esculenta Species 0.000 claims 2
- 235000007688 Lycopersicon esculentum Nutrition 0.000 claims 2
- 240000004658 Medicago sativa Species 0.000 claims 2
- 235000017587 Medicago sativa ssp. sativa Nutrition 0.000 claims 2
- 241001465754 Metazoa Species 0.000 claims 2
- 244000088415 Raphanus sativus Species 0.000 claims 2
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 claims 2
- 241000193448 Ruminiclostridium thermocellum Species 0.000 claims 2
- 240000003768 Solanum lycopersicum Species 0.000 claims 2
- 244000061456 Solanum tuberosum Species 0.000 claims 2
- 235000002595 Solanum tuberosum Nutrition 0.000 claims 2
- 244000300264 Spinacia oleracea Species 0.000 claims 2
- 235000009337 Spinacia oleracea Nutrition 0.000 claims 2
- 241000219793 Trifolium Species 0.000 claims 2
- 235000021307 Triticum Nutrition 0.000 claims 2
- 244000098338 Triticum aestivum Species 0.000 claims 2
- 240000004922 Vigna radiata Species 0.000 claims 2
- 235000010721 Vigna radiata var radiata Nutrition 0.000 claims 2
- 235000011469 Vigna radiata var sublobata Nutrition 0.000 claims 2
- 108010067390 Viral Proteins Proteins 0.000 claims 2
- 239000002671 adjuvant Substances 0.000 claims 2
- 229940037003 alum Drugs 0.000 claims 2
- 230000000890 antigenic effect Effects 0.000 claims 2
- 235000013399 edible fruits Nutrition 0.000 claims 2
- 239000000284 extract Substances 0.000 claims 2
- 108010051618 macrophage stimulatory lipopeptide 2 Proteins 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 230000001681 protective effect Effects 0.000 claims 2
- 239000001397 quillaja saponaria molina bark Substances 0.000 claims 2
- 229930182490 saponin Natural products 0.000 claims 2
- 150000007949 saponins Chemical class 0.000 claims 2
- 230000009261 transgenic effect Effects 0.000 claims 2
- 239000012646 vaccine adjuvant Substances 0.000 claims 2
- 229940124931 vaccine adjuvant Drugs 0.000 claims 2
- 230000003612 virological effect Effects 0.000 claims 2
- 235000011331 Brassica Nutrition 0.000 claims 1
- 244000068988 Glycine max Species 0.000 claims 1
- 241000208125 Nicotiana Species 0.000 claims 1
- 241000282887 Suidae Species 0.000 claims 1
- 230000024932 T cell mediated immunity Effects 0.000 claims 1
- 230000002349 favourable effect Effects 0.000 claims 1
- 230000001939 inductive effect Effects 0.000 claims 1
- 208000015181 infectious disease Diseases 0.000 claims 1
- 229940033324 influenza A vaccine Drugs 0.000 claims 1
- 238000001990 intravenous administration Methods 0.000 claims 1
- 238000007920 subcutaneous administration Methods 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US77337806P | 2006-02-13 | 2006-02-13 | |
| US81395506P | 2006-06-15 | 2006-06-15 | |
| PCT/US2007/003969 WO2007095318A2 (en) | 2006-02-13 | 2007-02-13 | Influenza antigens, vaccine compositions, and related methods |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009526526A JP2009526526A (ja) | 2009-07-23 |
| JP2009526526A5 true JP2009526526A5 (enExample) | 2009-09-03 |
Family
ID=38372128
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008554442A Withdrawn JP2009526526A (ja) | 2006-02-13 | 2007-02-13 | インフルエンザ抗原、ワクチン組成物、および関連する方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US8124103B2 (enExample) |
| EP (1) | EP1984405A4 (enExample) |
| JP (1) | JP2009526526A (enExample) |
| KR (1) | KR20080106433A (enExample) |
| CN (1) | CN101454347B (enExample) |
| AU (1) | AU2007215080A1 (enExample) |
| BR (1) | BRPI0707733B1 (enExample) |
| CA (1) | CA2642054C (enExample) |
| WO (1) | WO2007095318A2 (enExample) |
Families Citing this family (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9289487B2 (en) * | 1999-09-14 | 2016-03-22 | Antigen Express, Inc. | II-key/antigenic epitope hybrid peptide vaccines |
| CA2526720C (en) | 2003-05-22 | 2013-10-22 | Fraunhofer Usa, Inc. | Recombinant carrier molecule for expression, delivery and purification of target polypeptides |
| CA2616859C (en) * | 2005-08-03 | 2015-04-14 | Fraunhofer Usa, Inc. | Compositions and methods for production of immunoglobulins |
| BRPI0707779B8 (pt) * | 2006-02-13 | 2021-05-25 | Fraunhofer Usa Inc | antígeno isolado, composição de vacina e método para produção de uma proteína antígeno |
| WO2008048344A2 (en) * | 2006-02-13 | 2008-04-24 | Fraunhofer Usa, Inc. | Bacillus anthracis antigens, vaccine compositions, and related methods |
| US8404252B2 (en) * | 2007-07-11 | 2013-03-26 | Fraunhofer Usa, Inc. | Yersinia pestis antigens, vaccine compositions, and related methods |
| CA2615372A1 (en) | 2007-07-13 | 2009-01-13 | Marc-Andre D'aoust | Influenza virus-like particles (vlps) comprising hemagglutinin |
| US8470771B2 (en) | 2007-11-14 | 2013-06-25 | Institute Of Microbiology, Chinese Academy Of Sciences | Method and medicament for inhibiting the infection of influenza virus |
| CN103122354B (zh) | 2007-11-27 | 2018-03-23 | 麦迪卡格公司 | 表达血凝素之转基因植物中生产的重组流感病毒样颗粒(vlp) |
| WO2009152518A1 (en) * | 2008-06-13 | 2009-12-17 | Wisconsin Alumni Research Foundation | Novel peptide adjuvant for influenza vaccination |
| CA2727898A1 (en) | 2008-06-13 | 2009-12-17 | Wisconsin Alumni Research Foundation | Novel antiviral peptides against influenza virus |
| US8771703B2 (en) | 2008-07-08 | 2014-07-08 | Medicago Inc. | Soluble recombinant influenza antigens |
| AU2009270404B2 (en) | 2008-07-18 | 2015-01-29 | Medicago Inc. | New influenza virus immunizing epitope |
| WO2010036970A2 (en) * | 2008-09-25 | 2010-04-01 | Fraunhofer Usa, Inc. | Influenza vaccines, antigens, compositions, and methods |
| WO2010037046A1 (en) | 2008-09-28 | 2010-04-01 | Fraunhofer Usa, Inc. | Humanized neuraminidase antibody and methods of use thereof |
| KR101046004B1 (ko) * | 2008-11-12 | 2011-07-01 | 서울대학교산학협력단 | 돼지 인플루엔자 혈청 진단 방법 |
| US20140205619A1 (en) * | 2008-11-28 | 2014-07-24 | Biolex Therapeutics, Inc. | Recombinant avian influenza vaccine and uses thereof |
| WO2010088393A2 (en) * | 2009-01-28 | 2010-08-05 | Antigen Express, Inc. | Li-kay hybrid peptides that modulate the immune response to influenza |
| EP2413962A1 (en) | 2009-03-30 | 2012-02-08 | Mount Sinai School of Medicine | Influenza virus vaccines and uses thereof |
| CA2762042C (en) | 2009-06-24 | 2012-11-20 | Medicago Inc. | Chimeric influenza virus-like particles comprising hemagglutinin |
| KR102094253B1 (ko) | 2009-08-28 | 2020-03-31 | 이칸 스쿨 오브 메디슨 엣 마운트 시나이 | 산성 스핑고미엘리나제 결핍을 치료하기 위한 투여량 단계적 증가 효소 대체 요법 |
| HRP20171564T1 (hr) | 2009-09-22 | 2017-11-17 | Medicago Inc. | Postupak za pripremu biljnih čestica sličnih virusu (vlp) |
| US8784819B2 (en) | 2009-09-29 | 2014-07-22 | Ibio Inc. | Influenza hemagglutinin antibodies, compositions and related methods |
| MX2012011300A (es) | 2010-03-30 | 2012-11-29 | Sinai School Medicine | Vacunas del virus de influenza y usos de las mismas. |
| US9687536B2 (en) * | 2010-04-15 | 2017-06-27 | Shin Nippon Biomedical Laboratories, Ltd. | Methods and compositions for intranasal delivery |
| WO2011138032A2 (en) * | 2010-05-05 | 2011-11-10 | Artemev, Timur | Universal influenza vaccines and methods for their generation |
| TWI620816B (zh) | 2011-03-23 | 2018-04-11 | 苜蓿股份有限公司 | 植物衍生蛋白回收方法 |
| IN2014CN02114A (enExample) | 2011-09-20 | 2015-05-29 | Sinai School Medicine | |
| EP4154907A1 (en) | 2012-12-18 | 2023-03-29 | Icahn School of Medicine at Mount Sinai | Influenza virus vaccines and uses thereof |
| WO2014159960A1 (en) | 2013-03-14 | 2014-10-02 | Icahn School Of Medicine At Mount Sinai | Antibodies against influenza virus hemagglutinin and uses thereof |
| EP3092309B1 (en) | 2014-01-10 | 2021-02-24 | Medicago Inc. | Cpmv enhancer elements |
| JP2018504412A (ja) | 2015-01-23 | 2018-02-15 | アイカーン スクール オブ メディシン アット マウント サイナイ | インフルエンザウイルスワクチン接種レジメン |
| WO2017218624A1 (en) | 2016-06-15 | 2017-12-21 | Icahn School Of Medicine At Mount Sinai | Influenza virus hemagglutinin proteins and uses thereof |
| US11254733B2 (en) | 2017-04-07 | 2022-02-22 | Icahn School Of Medicine At Mount Sinai | Anti-influenza B virus neuraminidase antibodies and uses thereof |
| EP3810634A4 (en) | 2018-06-21 | 2022-07-27 | Icahn School of Medicine at Mount Sinai | Mosaic influenza virus hemagglutinin polypeptides and uses thereof |
| KR20200060969A (ko) | 2018-11-23 | 2020-06-02 | (주)셀트리온 | 인플루엔자 바이러스 질환을 치료하기 위한 투여 요법 |
| MX2023012554A (es) | 2018-12-12 | 2023-11-08 | Cambridge Tech Llc | Vacuna universal contra la gripe. |
| KR102444024B1 (ko) * | 2019-06-17 | 2022-09-20 | 주식회사 바이오앱 | 아프리카 돼지열병의 진단을 위한 항원 생산용 재조합 벡터 및 이의 용도 |
| US20240009298A1 (en) * | 2020-09-03 | 2024-01-11 | Flagship Pioneering Innovations Vi, Llc | Immunogenic compositions and uses thereof |
| CN117534737B (zh) * | 2022-07-15 | 2024-09-06 | 中山大学·深圳 | 一种季节性甲型流感通用Mosaic重组抗原及其疫苗和应用 |
| WO2025019631A1 (en) | 2023-07-19 | 2025-01-23 | Icahn School Of Medicine At Mount Sinai | Immunogenic compositions containing inactivated influenza a virus and cpg oligonucleotide adjuvant and uses thereof |
Family Cites Families (91)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4196265A (en) | 1977-06-15 | 1980-04-01 | The Wistar Institute | Method of producing antibodies |
| US4270537A (en) | 1979-11-19 | 1981-06-02 | Romaine Richard A | Automatic hypodermic syringe |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| JPS61134325A (ja) | 1984-12-04 | 1986-06-21 | Teijin Ltd | ハイブリツド抗体遺伝子の発現方法 |
| JPS61176721A (ja) | 1985-01-31 | 1986-08-08 | Mochizuki Motor Kk | マンホ−ル蓋の開閉運搬装置 |
| US4596556A (en) | 1985-03-25 | 1986-06-24 | Bioject, Inc. | Hypodermic injection apparatus |
| US5618920A (en) | 1985-11-01 | 1997-04-08 | Xoma Corporation | Modular assembly of antibody genes, antibodies prepared thereby and use |
| US4886499A (en) | 1986-12-18 | 1989-12-12 | Hoffmann-La Roche Inc. | Portable injection appliance |
| GB8704027D0 (en) | 1987-02-20 | 1987-03-25 | Owen Mumford Ltd | Syringe needle combination |
| US4940460A (en) | 1987-06-19 | 1990-07-10 | Bioject, Inc. | Patient-fillable and non-invasive hypodermic injection device assembly |
| US4941880A (en) | 1987-06-19 | 1990-07-17 | Bioject, Inc. | Pre-filled ampule and non-invasive hypodermic injection device assembly |
| US4790824A (en) | 1987-06-19 | 1988-12-13 | Bioject, Inc. | Non-invasive hypodermic injection device |
| US5316931A (en) | 1988-02-26 | 1994-05-31 | Biosource Genetics Corp. | Plant viral vectors having heterologous subgenomic promoters for systemic expression of foreign genes |
| US5339163A (en) | 1988-03-16 | 1994-08-16 | Canon Kabushiki Kaisha | Automatic exposure control device using plural image plane detection areas |
| US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
| GB8823869D0 (en) | 1988-10-12 | 1988-11-16 | Medical Res Council | Production of antibodies |
| FR2638359A1 (fr) | 1988-11-03 | 1990-05-04 | Tino Dalto | Guide de seringue avec reglage de la profondeur de penetration de l'aiguille dans la peau |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| DE3920358A1 (de) | 1989-06-22 | 1991-01-17 | Behringwerke Ag | Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung |
| US5064413A (en) | 1989-11-09 | 1991-11-12 | Bioject, Inc. | Needleless hypodermic injection device |
| US5312335A (en) | 1989-11-09 | 1994-05-17 | Bioject Inc. | Needleless hypodermic injection device |
| US5427908A (en) | 1990-05-01 | 1995-06-27 | Affymax Technologies N.V. | Recombinant library screening methods |
| US5190521A (en) | 1990-08-22 | 1993-03-02 | Tecnol Medical Products, Inc. | Apparatus and method for raising a skin wheal and anesthetizing skin |
| US5625126A (en) | 1990-08-29 | 1997-04-29 | Genpharm International, Inc. | Transgenic non-human animals for producing heterologous antibodies |
| US5661016A (en) | 1990-08-29 | 1997-08-26 | Genpharm International Inc. | Transgenic non-human animals capable of producing heterologous antibodies of various isotypes |
| KR100272077B1 (ko) | 1990-08-29 | 2000-11-15 | 젠팜인터내셔날,인코포레이티드 | 이종 항체를 생산할 수 있는 전이유전자를 가진 인간이외의 동물 |
| US5633425A (en) | 1990-08-29 | 1997-05-27 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
| US5770429A (en) | 1990-08-29 | 1998-06-23 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
| US5545806A (en) | 1990-08-29 | 1996-08-13 | Genpharm International, Inc. | Ransgenic non-human animals for producing heterologous antibodies |
| US5698426A (en) | 1990-09-28 | 1997-12-16 | Ixsys, Incorporated | Surface expression libraries of heteromeric receptors |
| US5527288A (en) | 1990-12-13 | 1996-06-18 | Elan Medical Technologies Limited | Intradermal drug delivery device and method for intradermal delivery of drugs |
| DK0531472T3 (da) | 1991-03-06 | 2003-12-01 | Merck Patent Gmbh | Humaniserede monoklonale antistoffer |
| DE69233750D1 (de) | 1991-04-10 | 2009-01-02 | Scripps Research Inst | Bibliotheken heterodimerer Rezeptoren mittels Phagemiden |
| GB9118204D0 (en) | 1991-08-23 | 1991-10-09 | Weston Terence E | Needle-less injector |
| SE9102652D0 (sv) | 1991-09-13 | 1991-09-13 | Kabi Pharmacia Ab | Injection needle arrangement |
| AU669124B2 (en) | 1991-09-18 | 1996-05-30 | Kyowa Hakko Kirin Co., Ltd. | Process for producing humanized chimera antibody |
| US5565332A (en) | 1991-09-23 | 1996-10-15 | Medical Research Council | Production of chimeric antibodies - a combinatorial approach |
| AU3178993A (en) | 1991-11-25 | 1993-06-28 | Enzon, Inc. | Multivalent antigen-binding proteins |
| GB9125979D0 (en) | 1991-12-06 | 1992-02-05 | Wellcome Found | Antibody |
| US5667988A (en) | 1992-01-27 | 1997-09-16 | The Scripps Research Institute | Methods for producing antibody libraries using universal or randomized immunoglobulin light chains |
| ZA931148B (en) | 1992-02-19 | 1993-08-18 | Schering Corp | Cloning and expression of humanized monoclonal antibodies against human interfluekin-4. |
| US5328483A (en) | 1992-02-27 | 1994-07-12 | Jacoby Richard M | Intradermal injection device with medication and needle guard |
| US5877289A (en) | 1992-03-05 | 1999-03-02 | The Scripps Research Institute | Tissue factor compositions and ligands for the specific coagulation of vasculature |
| US6093399A (en) | 1992-03-05 | 2000-07-25 | Board Of Regents, The University Of Texas System | Methods and compositions for the specific coagulation of vasculature |
| US5965132A (en) | 1992-03-05 | 1999-10-12 | Board Of Regents, The University Of Texas System | Methods and compositions for targeting the vasculature of solid tumors |
| CA2131528C (en) | 1992-03-05 | 2004-07-13 | Philip E. Thorpe | Methods and compositions for targeting the vasculature of solid tumors |
| US5733743A (en) | 1992-03-24 | 1998-03-31 | Cambridge Antibody Technology Limited | Methods for producing members of specific binding pairs |
| US5383851A (en) | 1992-07-24 | 1995-01-24 | Bioject Inc. | Needleless hypodermic injection device |
| US5639641A (en) | 1992-09-09 | 1997-06-17 | Immunogen Inc. | Resurfacing of rodent antibodies |
| US5569189A (en) | 1992-09-28 | 1996-10-29 | Equidyne Systems, Inc. | hypodermic jet injector |
| US5334144A (en) | 1992-10-30 | 1994-08-02 | Becton, Dickinson And Company | Single use disposable needleless injector |
| US5693506A (en) | 1993-11-16 | 1997-12-02 | The Regents Of The University Of California | Process for protein production in plants |
| WO1995024176A1 (en) | 1994-03-07 | 1995-09-14 | Bioject, Inc. | Ampule filling device |
| US5466220A (en) | 1994-03-08 | 1995-11-14 | Bioject, Inc. | Drug vial mixing and transfer device |
| EP0772619B2 (en) | 1994-07-15 | 2010-12-08 | The University of Iowa Research Foundation | Immunomodulatory oligonucleotides |
| US5599302A (en) | 1995-01-09 | 1997-02-04 | Medi-Ject Corporation | Medical injection system and method, gas spring thereof and launching device using gas spring |
| US5705154A (en) | 1995-03-08 | 1998-01-06 | Schering Corporation | Humanized monoclonal antibodies against human interleukin-4 |
| US5702892A (en) | 1995-05-09 | 1997-12-30 | The United States Of America As Represented By The Department Of Health And Human Services | Phage-display of immunoglobulin heavy chain libraries |
| US5730723A (en) | 1995-10-10 | 1998-03-24 | Visionary Medical Products Corporation, Inc. | Gas pressured needle-less injection device and method |
| US5893397A (en) | 1996-01-12 | 1999-04-13 | Bioject Inc. | Medication vial/syringe liquid-transfer apparatus |
| GB9607549D0 (en) | 1996-04-11 | 1996-06-12 | Weston Medical Ltd | Spring-powered dispensing device |
| US6042832A (en) | 1996-08-28 | 2000-03-28 | Thomas Jefferson University | Polypeptides fused with alfalfa mosaic virus or ilarvirus capsid proteins |
| ES2236634T3 (es) | 1997-04-07 | 2005-07-16 | Genentech, Inc. | Anticuerpos anti-vegf. |
| US5993412A (en) | 1997-05-19 | 1999-11-30 | Bioject, Inc. | Injection apparatus |
| PT1336621E (pt) | 1997-08-05 | 2006-08-31 | Stressgen Biotechnologies Corp | Respostas imunitarias contra antigenios dos vph, suscitadas por composicoes que incorporam um antigenio de vph e uma proteina do stress ou um vector de expressao com aptidao para a expressao destas proteinas |
| US6037456A (en) | 1998-03-10 | 2000-03-14 | Biosource Technologies, Inc. | Process for isolating and purifying viruses, soluble proteins and peptides from plant sources |
| US6044555A (en) | 1998-05-04 | 2000-04-04 | Keystone Powered Metal Company | Method for producing fully dense powdered metal helical gear |
| AU759813B2 (en) | 1998-08-11 | 2003-05-01 | Kentucky Bioprocessing, Llc | Method for recovering proteins from the interstitial fluid of plant tissues |
| CA2344269A1 (en) | 1998-10-07 | 2000-04-13 | Syngenta Participations Ag | Therapeutically active proteins in plants |
| WO2000025574A1 (en) | 1998-10-30 | 2000-05-11 | Thomas Jefferson University | Production of biomedical peptides and proteins in plants using plant virus vectors |
| JP2003517280A (ja) | 1999-02-05 | 2003-05-27 | トーマス・ジェファーソン・ユニバーシティ | トランス相補性システムを用いての植物における生物医学用ペプチド及びタンパク質の生成 |
| AU2001245823A1 (en) * | 2000-03-17 | 2001-10-03 | Corixa Corporation | Novel amphipathic aldehydes and their use as adjuvants and immunoeffectors |
| EP1294892B1 (en) * | 2000-06-23 | 2007-10-17 | Wyeth Holdings Corporation | Assembly of wild-type and chimeric influenza virus-like particles (vlps) |
| KR100919266B1 (ko) | 2000-06-26 | 2009-09-30 | 엔벤타 바이오파마슈티컬스 코포레이션 | 인간 파필로마 바이러스 치료법 |
| UA80809C2 (en) | 2001-11-05 | 2007-11-12 | Process for preparation of protective antigen protein of anthracis with e.coli | |
| US20040170606A1 (en) | 2002-06-07 | 2004-09-02 | Palmer Kenneth E. | Production of peptides in plants as viral coat protein fusions |
| US7683238B2 (en) | 2002-11-12 | 2010-03-23 | iBio, Inc. and Fraunhofer USA, Inc. | Production of pharmaceutically active proteins in sprouted seedlings |
| EP1594956A4 (en) | 2003-02-03 | 2007-08-01 | Fraunhofer Usa Inc | SYSTEM FOR EXPRESSION OF GENES IN PLANTS |
| JP2007526215A (ja) | 2003-05-05 | 2007-09-13 | ダウ アグロサイエンス リミテッド ライアビリティー カンパニー | トランスジェニック植物細胞に由来する安定な免疫予防的および治療的組成物ならびにその産生方法 |
| DE602004028004D1 (de) * | 2003-05-05 | 2010-08-19 | Thompson Boyce Plant Res | Vektoren und zellen zur herstellung von aus transgenen pflanzen gewonnenen immunprotektiven zusammensetzungen |
| CA2526720C (en) * | 2003-05-22 | 2013-10-22 | Fraunhofer Usa, Inc. | Recombinant carrier molecule for expression, delivery and purification of target polypeptides |
| CA2816222A1 (en) * | 2003-06-16 | 2005-03-03 | Medimmune Vaccines, Inc. | Influenza hemagglutinin and neuraminidase variants |
| US7888135B2 (en) | 2004-04-23 | 2011-02-15 | University Of Georgia Research Foundation, Inc. | Diagnostic assay for Trypanosoma cruzi infection |
| EP2530147B1 (en) * | 2004-05-25 | 2014-09-10 | MedImmune, LLC | Influenza hemagglutinin and neuraminidase variants |
| BRPI0707779B8 (pt) | 2006-02-13 | 2021-05-25 | Fraunhofer Usa Inc | antígeno isolado, composição de vacina e método para produção de uma proteína antígeno |
| WO2008033105A1 (en) | 2006-09-13 | 2008-03-20 | Dso National Laboratories | Hemagglutinin antibody and uses thereof |
| EP2061808A4 (en) | 2006-09-15 | 2009-11-18 | Fraunhofer Usa Inc | INFLUENZA ANTIBODIES, COMPOSITIONS AND RELATED METHODS |
| BRPI0810865A2 (pt) | 2007-04-28 | 2017-05-09 | Fraunhofer Usa Inc | antígenos de tripanossoma, composições vacinais, e métodos relacionados |
| US8404252B2 (en) | 2007-07-11 | 2013-03-26 | Fraunhofer Usa, Inc. | Yersinia pestis antigens, vaccine compositions, and related methods |
| CA2696764A1 (en) | 2007-08-20 | 2009-02-26 | Fraunhofer Usa, Inc. | Prophylactic and therapeutic influenza vaccines, antigens, compositions, and methods |
| WO2010037046A1 (en) | 2008-09-28 | 2010-04-01 | Fraunhofer Usa, Inc. | Humanized neuraminidase antibody and methods of use thereof |
-
2007
- 2007-02-13 AU AU2007215080A patent/AU2007215080A1/en not_active Abandoned
- 2007-02-13 JP JP2008554442A patent/JP2009526526A/ja not_active Withdrawn
- 2007-02-13 CA CA2642054A patent/CA2642054C/en active Active
- 2007-02-13 BR BRPI0707733-5A patent/BRPI0707733B1/pt not_active IP Right Cessation
- 2007-02-13 WO PCT/US2007/003969 patent/WO2007095318A2/en not_active Ceased
- 2007-02-13 CN CN2007800080983A patent/CN101454347B/zh active Active
- 2007-02-13 KR KR1020087022551A patent/KR20080106433A/ko not_active Ceased
- 2007-02-13 EP EP07750784A patent/EP1984405A4/en not_active Withdrawn
- 2007-02-13 US US11/706,573 patent/US8124103B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009526526A5 (enExample) | ||
| JP2009526780A5 (enExample) | ||
| Berinstein et al. | Mucosal and systemic immunization elicited by Newcastle disease virus (NDV) transgenic plants as antigens | |
| Zhang et al. | Advancements in the development of subunit influenza vaccines | |
| JP5813505B2 (ja) | 新規インフルエンザウイルス免疫エピトープ | |
| Kerstetter et al. | Adenoviral vectors as vaccines for emerging avian influenza viruses | |
| US20110059130A1 (en) | Prophylactic and therapeutic influenza vaccines, antigens, compositions and methods | |
| Bouche et al. | Neutralising immunogenicity of a polyepitope antigen expressed in a transgenic food plant: a novel antigen to protect against measles | |
| AU2007215080A1 (en) | Influenza antigens, vaccine compositions, and related methods | |
| US7901691B2 (en) | Chimeric G protein based rabies vaccine | |
| Wang et al. | Immunogenicity of foot-and-mouth disease virus structural polyprotein P1 expressed in transgenic rice | |
| US12257302B2 (en) | Universal vaccine platform | |
| Zhang et al. | Recombinant baculovirus vaccine containing multiple M2e and adjuvant LTB induces T cell dependent, cross-clade protection against H5N1 influenza virus in mice | |
| Allen et al. | mRNA vaccines encoding computationally optimized hemagglutinin elicit protective antibodies against future antigenically drifted H1N1 and H3N2 influenza viruses isolated between 2018-2020 | |
| US20130004547A1 (en) | Oral vaccines produced and administered using edible micro-organisms including lactic acid bacterial strains | |
| US20120171230A1 (en) | Oral vaccines produced and administered using edible micro-organism | |
| Gasparini et al. | Live attenuated influenza vaccine–a review | |
| Park et al. | Preparation and immunogenicity of influenza virus-like particles using nitrocellulose membrane filtration | |
| WO2003013598A2 (en) | Novel vaccine compositions and methods of vaccine preparation for veterinary and human diseases | |
| Yang et al. | A novel H6N1 virus-like particle vaccine induces long-lasting cross-clade antibody immunity against human and avian H6N1 viruses | |
| Meriç et al. | Plant-based vaccines: The future of preventive healthcare | |
| Abolnik | Molecular epidemiology of Newcastle disease and avian influenza in South Africa | |
| US10376574B2 (en) | Compositions and methods for vaccination against influenza A virus | |
| US20230173055A1 (en) | Influenza virus surface protein-derived recombinant hemagglutinin protein forming trimer, and use thereof | |
| US10953086B2 (en) | Universal influenza vaccine using cold-adapted live-attenuated virus |